MDT Q1 2023 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$116B

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7.4B-7.7% YoY

Gross Profit

$4.9B65.9% margin

Operating Income

$1.1B15.3% margin

Net Income

$929M12.6% margin

EPS (Diluted)

$0.70

QoQ Revenue Growth

-8.9%

Cash Flow

Operating Cash Flow

$1.1B

Free Cash Flow

$657M

Stock-Based Comp.

$62M

Balance Sheet

Total Assets

$89.9B

Total Liabilities

$37.1B

Stockholders' Equity

$52.7B

Cash & Equivalents

$2.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.4B	$8.0B	-7.7%
Gross Profit	$4.9B	$5.4B	-9.9%
Operating Income	$1.1B	$859M	+31.0%
Net Income	$929M	$763M	+21.8%

Revenue Segments

Cardiovascular

$2.7B37%

Neuroscience Group

$2.1B29%

Medical Surgical

$2.0B27%

Diabetes Group

$541M7%

Geographic Segments

UNITED STATES

$3.8B51%

Total Other Countries, Excluding United States and Ireland

$3.6B49%

IRELAND

$23M0%